Literature DB >> 29979859

[In vivo study of Chuankezhi metabolism in rat].

Qian-ru Feng, Jie-jing Yu, Jing-jing Zhan, Yi-juan Xu, Yeuk-lung Chow, Shun-jun Xu, Liu Yang.   

Abstract

To study the metabolic products of main compounds of Chuankezhi injection in rat, 12 Sprague Dawley rats were classed into 2 groups, a blank control group and an intermuscular administration group, respectively. Rat feces and urine samples were collected from 0−24 h and 24−48 h after administration. All the samples were ultrasonically treated with methanol and then analyzed using LC-LTQ Orbitrap MSn. By comparison with the total ion chromatogram of samples from the blank control group, the metabolites in the samples of drug-treated group were screened. These metabolites were further analyzed by multistage product ion scanning and comparison of retention time with reference substances. As a result, a total of 12 flavonoid metabolites were tentatively identified from the rat feces and no metabolite was discovered in the rat urine. Epimedin C and icariin were detected in the rat blood samples after 30 min of administration, but their metabolites and other original flavones were not detected. Furthermore, no original flavones and their metabolites were detected in rat blood samples after 2 and 4 h of administration. The potential metabolism paths were further characterized and the principal in vivo transformation of flavones from Chuankezhi injection were deglycosylation, dehydration, methylation, oxidation and isomerization in rats.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29979859

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Chuankezhi injection for asthma: Protocol of a systematic review and meta-analysis.

Authors:  Meichen Li; Wenjiang Zheng; Chaoyuan Zhang; Qian Yan; Zijing Peng; Fuqi Xie; Yu Hong; Xiaohong Liu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

2.  New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action.

Authors:  Rui Liang; Xiang-Na Yang; Shan Lin; Wei-Qing Yi; Xiao-Gang Chen; Xin Dong; Long-Gang Guo; Yan-Kun Li; Yue-Rui Zhao; Hua Xu
Journal:  Ann Transl Med       Date:  2022-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.